• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Performance of Algorithms Submitted in the 2023 RSNA Screening Mammography Breast Cancer Detection AI Challenge.

作者信息

Chen Yan, Partridge George J W, Vazirabad Maryam, Ball Robyn L, Trivedi Hari M, Kitamura Felipe Campos, Frazer Helen M L, Retson Tara A, Yao Luyan, Darker Iain T, Kelil Tatiana, Mongan John, Mann Ritse M, Moy Linda

机构信息

Translational Medical Sciences, School of Medicine, University of Nottingham, Clinical Sciences Building, Nottingham NG5 1PB, United Kingdom.

Informatics Department, Radiological Society of North America, Oak Brook, Ill.

出版信息

Radiology. 2025 Aug;316(2):e241447. doi: 10.1148/radiol.241447.

DOI:10.1148/radiol.241447
PMID:40793948
Abstract

Background The 2023 RSNA Screening Mammography Breast Cancer Detection AI Challenge invited participants to develop artificial intelligence (AI) models capable of independently interpreting mammograms. Purpose To assess the performance of the submitted algorithms, explore the potential for improving performance by combining the best-performing AI algorithms, and investigate how performance was influenced by the demographic and clinical characteristics of the evaluation cohort. Materials and Methods A total of 1687 AI algorithms were submitted from November 2022 to February 2023. Of these, 1537 algorithms were assessed using an evaluation dataset from two sites-one in the United States and one in Australia. Cancer cases were identified at screening and confirmed with pathologic examination; noncancer cases were followed up for at least 1 year. Results for ensemble models of top algorithms were computed by recalling a case when any of the included algorithms indicated recall. Odds ratios (ORs) were used to investigate differences in AI performance when the dataset was stratified by clinical or demographic characteristics. Results The evaluation dataset consisted of 5415 women (median age, 59 years [IQR, 52-66 years]). Among the 1537 AI algorithms, the median recall rate, sensitivity, specificity, and positive predictive value (PPV) were 1.7%, 27.6%, 98.7%, and 36.9%, respectively. For the top-ranked algorithm, the recall rate, sensitivity, specificity, and PPV were 1.5%, 48.6%, 99.5%, and 64.6%, respectively. Ensemble models of the top 3 and top 10 algorithms had a sensitivity of 60.7% and 67.8%, respectively; the corresponding recall rates were 2.4% and 3.5%, and the corresponding specificities were 98.8% and 97.8%. Lower sensitivity was observed for the U.S. dataset than for the Australian dataset (top 3 ensemble model: 52.0% vs 68.1%; OR = 0.51; = .02), and greater sensitivity was observed for invasive cancers than for noninvasive cancers (top 3 ensemble model: 68.0% vs 43.8%; OR = 2.73; = .001). Conclusion The different AI algorithms identified different cancers during screening mammography, and ensemble models had increased sensitivity while maintaining low recall rates. © RSNA, 2025

摘要

相似文献

1
Performance of Algorithms Submitted in the 2023 RSNA Screening Mammography Breast Cancer Detection AI Challenge.
Radiology. 2025 Aug;316(2):e241447. doi: 10.1148/radiol.241447.
2
AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis.人工智能降低筛查数字化乳腺断层合成的间期癌发生率
Radiology. 2025 Jul;316(1):e241050. doi: 10.1148/radiol.241050.
3
External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers.一种用于检测假阴性乳腺癌的商业人工智能算法在不同人群中的外部验证
J Breast Imaging. 2025 Jan 25;7(1):16-26. doi: 10.1093/jbi/wbae058.
4
Influence of AI Decision Support on Radiologists' Performance and Visual Search in Screening Mammography.人工智能决策支持对乳腺钼靶筛查中放射科医生表现及视觉搜索的影响
Radiology. 2025 Jul;316(1):e243688. doi: 10.1148/radiol.243688.
5
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
6
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection.人工智能算法用于早期乳腺癌检测。
JAMA Netw Open. 2024 Oct 1;7(10):e2437402. doi: 10.1001/jamanetworkopen.2024.37402.
7
Screening for Breast Cancer with Contrast-enhanced Mammography as an Alternative to MRI: SCEMAM Trial Results.对比增强乳腺钼靶筛查作为MRI替代方法用于乳腺癌筛查:SCEMAM试验结果
Radiology. 2025 Jun;315(3):e242634. doi: 10.1148/radiol.242634.
8
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺 X 线摄影联合乳腺超声与乳腺 X 线摄影用于一般风险女性乳腺癌筛查。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3.
9
Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer.乳腺癌家族史女性的断层合成成像与数字乳腺摄影筛查对比
JAMA Oncol. 2025 May 22. doi: 10.1001/jamaoncol.2025.1209.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.